NasdaqCM - Nasdaq Real Time Price USD
Coeptis Therapeutics Holdings, Inc. (COEP)
At close: November 6 at 4:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.39 | -0.23 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 9/30/2023 | 12/31/2023 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.28 | -0.01 | -0.12 | -0.09 |
| EPS Actual | -0.39 | -0.23 | -0.11 | -0.08 |
| Difference | -0.11 | -0.22 | 0.01 | 0.01 |
| Surprise % | -39.30% | -2,200.00% | 8.30% | 11.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.05 | -0.04 | -0.26 | -0.17 |
| 30 Days Ago | -0.05 | -0.04 | -0.26 | -0.17 |
| 60 Days Ago | -0.05 | -0.04 | -0.26 | -0.17 |
| 90 Days Ago | -0.05 | -0.04 | -0.26 | -0.17 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | COEP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 12.70% |
| Current Year | -- | -- | -- | 2.10% |
| Next Year | -- | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Ladenburg Thalmann: Buy | 9/22/2023 |
| Reiterates | EF Hutton: Buy to Buy | 5/18/2023 |
| Reiterates | EF Hutton: Buy | 5/10/2023 |
| Initiated | JonesTrading: Buy | 4/19/2023 |
| Reiterates | EF Hutton: Buy | 4/5/2023 |
| Reiterates | EF Hutton: Buy | 3/29/2023 |
Related Tickers
ESLA Estrella Immunopharma, Inc.
0.7902
-3.16%
FRES Fresh2 Group Limited
1.3864
-15.98%
NRBO NeuroBo Pharmaceuticals, Inc.
2.7400
+7.87%
PTIX Protagenic Therapeutics, Inc.
0.6000
-4.76%
MLEC Moolec Science SA
0.8800
+0.49%
CYTO Altamira Therapeutics Ltd.
0.5049
-2.72%
CERO CERo Therapeutics Holdings, Inc.
0.0720
-1.77%
GANX Gain Therapeutics, Inc.
2.2700
+2.25%
RENB Renovaro Inc.
0.6254
+5.30%
SLXN Silexion Therapeutics Corp
0.2559
-2.92%